The global proteomics market size is expected to reach USD 68.83 billion by 2030, according to a new study by Polaris Market Research. The report “Proteomics Market Share, Size, Trends, Industry Analysis Report, By Product Type (Instruments, Reagents & Kits, Services); By Application; By Technology; By Region; Segment Forecast, 2022 - 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Increased investments by leading players in the development of improved and effective medications and diagnostic technologies are expected to promote proteomics market expansion over the forecast period. For example, Bruker Corp. will release two new Tim stop equipment in June 2021.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/proteomics-market/request-for-sample
It enables the development of innovative methods and applications, including epiproteomics/PTM characterization and the discovery of unbiased and comprehensive multi-omic biomarkers. They also improve and facilitate these unique applications and methodologies in cancer liquid biopsy research. Such corporate activities are likely to augment market expansion in the coming years.
These key drivers will continue to propel the biopharmaceutical industry's pursuit of breakthrough pharmaceuticals as well as recent technology improvements in gene and protein research. In December 2020, Thermo Fisher Scientific announced the successful conclusion of its purchase of Phitonex, Inc., a North Carolina-based company that essentially invented a spectroscopic dye platform for elevated biology applications to accelerate research and development in immuno-oncology, cell therapy, and immunology research.
The addition of Phitonex's products will allow Thermo company to offer more flow cytometry and image multiplexing capabilities to address evolving client needs in proteins and cell analysis investigations. Because it is difficult for corporations to locate all of the necessary knowledge to cover all of the tasks involved in proteomics, alliances are becoming increasingly essential in this market. Further, another factor expected to propel market expansion is the increased prevalence of chronic diseases such as cancer, Cardiovascular Disorders (CVDs), respiratory diseases, CKD, and many others. Thus, as the prevalence of life-threatening diseases rises, so does the need for tailored therapeutics, resulting in a beneficial impact on the sector.
Proteomics Market Report Highlights
Polaris Market Research has segmented the proteomics market report based on technology, product type, application, and region:
Proteomics, Product Type Outlook (Revenue - USD Billion, 2018 - 2030)
Proteomics, Application Outlook (Revenue - USD Billion, 2018 - 2030)
Proteomics, Technology Outlook (Revenue - USD Billion, 2018 - 2030)
Proteomics, Regional Outlook (Revenue - USD Billion, 2018 - 2030)